André J. Müller

Director/Board Member at

Anokion SA

82 year

45 connections

Health Technology

Consumer Services

Finance

Profile

André J.
Müller was the founder of Actelion Ltd. (1999) where he held the title of Vice Chairman in 2009.
Mr. Müller is also the founder of REFERENCE CAPITAL SA. Currently, he is a Director at Anokion SA. Previously, he held the position of Chairman at Addex Therapeutics Ltd. (2002-2014) and ABIONYX Pharma SA. He was also a Director at Synthes, Inc., Kanyos Bio, Inc., and Chief Financial Officer at Biogen, Inc. Mr. Müller received an MBA from INSEAD and an undergraduate degree from the University of Geneva.

André J. Müller active positions

Companies	Position	Start
Anokion SA Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance	Director/Board Member	-

All active positions of André J. Müller

Former positions of André J. Müller

Companies	Position	End
ADDEX THERAPEUTICS LTD	Chairman	27/06/2014
ACTELION	Founder	01/04/2009
Kanyos Bio, Inc. Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes	Director/Board Member	-
REFERENCE CAPITAL SA REFERENCE CAPITAL SA Investment ManagersFinance Genevest's portfolio of investments has reached maturity. The firm primarily oversees exit operations through trade sales and IPOs. Their past investments focused on sectors such as IT, communications, materials science, medical technology and life sciences, primarily in Europe and selectively in the US and Israel. The firm typically holds minority stakes in syndication with other investors, and generally does not sit on the board of their portfolio companies.	Founder	-
Synthes, Inc. Synthes, Inc. Medical SpecialtiesHealth Technology Develops, produces & markets instruments, implants and biomaterials for surgical fixation, correction, regeneration of human skeleton & soft tissues	Director/Board Member	-

See the detail of André J. Müller's experience

Training of André J. Müller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of André J. Müller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Synthes, Inc. Synthes, Inc. Medical SpecialtiesHealth Technology Develops, produces & markets instruments, implants and biomaterials for surgical fixation, correction, regeneration of human skeleton & soft tissues	Health Technology
Actelion Ltd. Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs	Health Technology
INSEAD INSEAD Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
REFERENCE CAPITAL SA REFERENCE CAPITAL SA Investment ManagersFinance Genevest's portfolio of investments has reached maturity. The firm primarily oversees exit operations through trade sales and IPOs. Their past investments focused on sectors such as IT, communications, materials science, medical technology and life sciences, primarily in Europe and selectively in the US and Israel. The firm typically holds minority stakes in syndication with other investors, and generally does not sit on the board of their portfolio companies.	Finance
Addex Therapeutics Ltd. Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs	Health Technology
University of Geneva University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ABIONYX Pharma SA ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases	Health Technology
Anokion SA Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance	Health Technology
Kanyos Bio, Inc. Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes	Health Technology